Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar, Liana Herlina. Cost-Effectiveness of Pembrolizumab as First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review. the int. j. of med. science and health [Internet]. 2026 Jan. 4 [cited 2026 Oct. 21];23(2):64-130. Available from: https://internationalmedicaljournal.org/index.php/ijmhsr/article/view/461